Código QR

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis

IntroductionThis meta-analysis aimed to evaluate the efficacy and safety of Lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors (PD-1 inhibitors) in the treatment of intermediate or advanced hepatocellular carcinoma (HCC).Materials and MethodsFour databases...

Descrición completa

Gardado en:
Principais autores: Yongfa Lei, Xiaotian Liang, Hua Zhu, Jin Wang, Xiaochen Zhang, Siliang Duan, Weiming Liang
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Assuntos:
hepatocellular carcinoma
lenvatinib
PD-1 inhibitor
transarterial chemoembolization
progression-free survival
overall survival
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586914/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares